2P4Y - Header Asymmetric Unit

HEADER TRANSCRIPTION 13-MAR-07 2P4Y

TITLE CRYSTAL STRUCTURE OF HUMAN PPAR-GAMMA-LIGAND BINDING DOMAIN TITLE 2 COMPLEXED WITH AN INDOLE-BASED MODULATOR

COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND-BINDING DOMAIN (LBD), RESIDUES 231-505; COMPND 5 SYNONYM: PPAR-GAMMA; COMPND 6 ENGINEERED: YES

SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PPARG, NR1C3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGEX4T2

KEYWDS NUCLEAR RECEPTOR, LIGAND BINDING DOMAIN, LBD, ALPHA HELIX KEYWDS 2 SANDWICH, PPAR-HOMODIMER, SPPARGM, PARTIAL AGONIST, KEYWDS 3 TRANSCRIPTION

EXPDTA X-RAY DIFFRACTION

AUTHOR B.M.MCKEEVER

REVDAT 2 24-FEB-09 2P4Y 1 VERSN REVDAT 1 08-JAN-08 2P4Y 0

JRNL AUTH M.EINSTEIN,T.E.AKIYAMA,G.A.CASTRIOTA,C.F.WANG, JRNL AUTH 2 B.MCKEEVER,R.T.MOSLEY,J.W.BECKER,D.E.MOLLER, JRNL AUTH 3 P.T.MEINKE,H.B.WOOD,J.P.BERGER JRNL TITL THE DIFFERENTIAL INTERACTIONS OF PEROXISOME JRNL TITL 2 PROLIFERATOR-ACTIVATED RECEPTOR GAMMA LIGANDS WITH JRNL TITL 3 TYR473 IS A PHYSICAL BASIS FOR THEIR UNIQUE JRNL TITL 4 BIOLOGICAL ACTIVITIES. JRNL REF MOL.PHARMACOL. V. 73 62 2008 JRNL REFN ISSN 0026-895X JRNL PMID 17940191 JRNL DOI 10.1124/MOL.107.041202

REMARK 1

REMARK 2 REMARK 2 RESOLUTION. 2.25 ANGSTROMS.

REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2005 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.34 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 169416.600 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 94.5 REMARK 3 NUMBER OF REFLECTIONS : 28327 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.232 REMARK 3 R VALUE (WORKING SET) : 0.232 REMARK 3 FREE R VALUE : 0.274 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1402 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 28327 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.25 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.39 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 82.10 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3890 REMARK 3 BIN R VALUE (WORKING SET) : 0.3240 REMARK 3 BIN FREE R VALUE : 0.3830 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 210 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.026 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3792 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 88 REMARK 3 SOLVENT ATOMS : 93 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 29.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 43.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -8.41000 REMARK 3 B22 (A**2) : 9.36000 REMARK 3 B33 (A**2) : -0.95000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 2.34000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.30 REMARK 3 ESD FROM SIGMAA (A) : 0.42 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.37 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.37 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 0.90 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 20.60 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.66 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.450 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.300 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.230 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.370 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.37 REMARK 3 BSOL : 45.47 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.P REMARK 3 PARAMETER FILE 2 : WATER_REP.PAR REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : TRI.PAR REMARK 3 PARAMETER FILE 5 : C02.PAR REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : TRI.TOP REMARK 3 TOPOLOGY FILE 5 : C02.TOP REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: MAXIMUM LIKELIHOOD FUNCTION BASED ON REMARK 3 F

REMARK 4 REMARK 4 2P4Y COMPLIES WITH FORMAT V. 3.15, 01-DEC-08

REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-APR-07. REMARK 100 THE RCSB ID CODE IS RCSB041971.

REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-APR-02 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29681 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.250 REMARK 200 RESOLUTION RANGE LOW (A) : 40.340 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 5.000 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 15.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.35 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.35330 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.510 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNX 2005 REMARK 200 STARTING MODEL: SE-MET PPAR-GAMMA-LBD COMPLEX REMARK 200 REMARK 200 REMARK: NULL

REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.15 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.52 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.95M TRISODIUM CITRATE, 0.1M TRIS- REMARK 280 HCL PH 8.5, 1MM TCEP, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 298K

REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 46.07400 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.92950 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 46.07400 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 29.92950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL

REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 2 CHAINS. SEE REMARK 350 FOR INFORMATION REMARK 300 ON GENERATING THE BIOLOGICAL MOLECULE. REMARK 300 AUTHORS STATE THAT A PPARGAMMA HOMODIMER IS AN ARTIFACT OF REMARK 300 CRYSTALLIZATION WHICH MAY SERVE AS A MODEL FOR AN ASSEMBLY REMARK 300 OF THE BIOLOGICALLY IMPORTANT HETERODIMER PPAR-RXR.

REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000

REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 201 REMARK 465 SER A 202 REMARK 465 GLN A 203 REMARK 465 LEU A 204 REMARK 465 GLY A 239 REMARK 465 LYS A 240 REMARK 465 THR A 241 REMARK 465 THR A 242 REMARK 465 ASP A 243 REMARK 465 LEU A 255 REMARK 465 MET A 256 REMARK 465 MET A 257 REMARK 465 GLY A 258 REMARK 465 GLU A 259 REMARK 465 ASP A 260 REMARK 465 LYS A 261 REMARK 465 ILE A 262 REMARK 465 LYS A 263 REMARK 465 PHE A 264 REMARK 465 LYS A 265 REMARK 465 HIS A 266 REMARK 465 ILE A 267 REMARK 465 THR A 268 REMARK 465 PRO A 269 REMARK 465 LEU A 270 REMARK 465 GLN A 271 REMARK 465 GLU A 272 REMARK 465 GLN A 273 REMARK 465 SER A 274 REMARK 465 LYS A 275 REMARK 465 GLU A 276 REMARK 465 VAL A 277 REMARK 465 ALA A 278 REMARK 465 GLY B 201 REMARK 465 SER B 202 REMARK 465 GLN B 203 REMARK 465 LEU B 204 REMARK 465 ASN B 205 REMARK 465 PRO B 206 REMARK 465 GLU B 207 REMARK 465 SER B 208 REMARK 465 THR B 238 REMARK 465 GLY B 239 REMARK 465 LYS B 240 REMARK 465 THR B 241 REMARK 465 THR B 242 REMARK 465 ASP B 243 REMARK 465 LYS B 244 REMARK 465 LEU B 255 REMARK 465 MET B 256 REMARK 465 MET B 257 REMARK 465 GLY B 258 REMARK 465 GLU B 259 REMARK 465 ASP B 260 REMARK 465 LYS B 261 REMARK 465 ILE B 262 REMARK 465 LYS B 263 REMARK 465 PHE B 264 REMARK 465 LYS B 265 REMARK 465 HIS B 266 REMARK 465 ILE B 267 REMARK 465 THR B 268 REMARK 465 PRO B 269 REMARK 465 LEU B 270 REMARK 465 GLN B 271 REMARK 465 GLU B 272 REMARK 465 GLN B 273 REMARK 465 SER B 274 REMARK 465 LYS B 275 REMARK 465 GLU B 276 REMARK 465 VAL B 277 REMARK 465 GLN B 454 REMARK 465 VAL B 455 REMARK 465 ILE B 456 REMARK 465 LYS B 457 REMARK 465 LYS B 458 REMARK 465 THR B 459 REMARK 465 GLU B 460 REMARK 465 THR B 461 REMARK 465 ASP B 462 REMARK 465 MET B 463 REMARK 465 SER B 464 REMARK 465 LEU B 465

REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 253 99.99 -59.37 REMARK 500 LYS A 358 -156.73 53.02 REMARK 500 THR A 461 0.91 -68.44 REMARK 500 LYS A 474 -70.33 -47.86 REMARK 500 ASP A 475 -91.55 -71.77 REMARK 500 LEU A 476 -122.68 70.15 REMARK 500 TYR B 473 40.37 -105.88 REMARK 500 ASP B 475 -73.27 80.88 REMARK 500 REMARK 500 REMARK: NULL

REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE C03 A 478 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE C03 B 478 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TRS A 479

REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1ZEO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN PPAR-GAMMA LIGAND BINDING DOMAIN REMARK 900 COMPLEXED WITH AN ALPHA-ARYLOXYPHENYLACETIC ACID AGONIST

REMARK 999 REMARK 999 SEQUENCE REMARK 999 AUTHORS STATE THAT RESIDUES GLY 201 AND SER 202 IN REMARK 999 CHAINS A AND B ARE THE REMNANTS OF A THROMBIN-CLEAVAGE REMARK 999 SITE BETWEEN GLUTATHIONE-S-TRANSFERASE AND PPARGAMMA-LBD.

DBREF 2P4Y A 203 477 UNP P37231 PPARG_HUMAN 231 505 DBREF 2P4Y B 203 477 UNP P37231 PPARG_HUMAN 231 505

SEQADV 2P4Y GLY A 201 UNP P37231 EXPRESSION TAG SEQADV 2P4Y SER A 202 UNP P37231 EXPRESSION TAG SEQADV 2P4Y GLY B 201 UNP P37231 EXPRESSION TAG SEQADV 2P4Y SER B 202 UNP P37231 EXPRESSION TAG

SEQRES 1 A 277 GLY SER GLN LEU ASN PRO GLU SER ALA ASP LEU ARG ALA SEQRES 2 A 277 LEU ALA LYS HIS LEU TYR ASP SER TYR ILE LYS SER PHE SEQRES 3 A 277 PRO LEU THR LYS ALA LYS ALA ARG ALA ILE LEU THR GLY SEQRES 4 A 277 LYS THR THR ASP LYS SER PRO PHE VAL ILE TYR ASP MET SEQRES 5 A 277 ASN SER LEU MET MET GLY GLU ASP LYS ILE LYS PHE LYS SEQRES 6 A 277 HIS ILE THR PRO LEU GLN GLU GLN SER LYS GLU VAL ALA SEQRES 7 A 277 ILE ARG ILE PHE GLN GLY CYS GLN PHE ARG SER VAL GLU SEQRES 8 A 277 ALA VAL GLN GLU ILE THR GLU TYR ALA LYS SER ILE PRO SEQRES 9 A 277 GLY PHE VAL ASN LEU ASP LEU ASN ASP GLN VAL THR LEU SEQRES 10 A 277 LEU LYS TYR GLY VAL HIS GLU ILE ILE TYR THR MET LEU SEQRES 11 A 277 ALA SER LEU MET ASN LYS ASP GLY VAL LEU ILE SER GLU SEQRES 12 A 277 GLY GLN GLY PHE MET THR ARG GLU PHE LEU LYS SER LEU SEQRES 13 A 277 ARG LYS PRO PHE GLY ASP PHE MET GLU PRO LYS PHE GLU SEQRES 14 A 277 PHE ALA VAL LYS PHE ASN ALA LEU GLU LEU ASP ASP SER SEQRES 15 A 277 ASP LEU ALA ILE PHE ILE ALA VAL ILE ILE LEU SER GLY SEQRES 16 A 277 ASP ARG PRO GLY LEU LEU ASN VAL LYS PRO ILE GLU ASP SEQRES 17 A 277 ILE GLN ASP ASN LEU LEU GLN ALA LEU GLU LEU GLN LEU SEQRES 18 A 277 LYS LEU ASN HIS PRO GLU SER SER GLN LEU PHE ALA LYS SEQRES 19 A 277 LEU LEU GLN LYS MET THR ASP LEU ARG GLN ILE VAL THR SEQRES 20 A 277 GLU HIS VAL GLN LEU LEU GLN VAL ILE LYS LYS THR GLU SEQRES 21 A 277 THR ASP MET SER LEU HIS PRO LEU LEU GLN GLU ILE TYR SEQRES 22 A 277 LYS ASP LEU TYR SEQRES 1 B 277 GLY SER GLN LEU ASN PRO GLU SER ALA ASP LEU ARG ALA SEQRES 2 B 277 LEU ALA LYS HIS LEU TYR ASP SER TYR ILE LYS SER PHE SEQRES 3 B 277 PRO LEU THR LYS ALA LYS ALA ARG ALA ILE LEU THR GLY SEQRES 4 B 277 LYS THR THR ASP LYS SER PRO PHE VAL ILE TYR ASP MET SEQRES 5 B 277 ASN SER LEU MET MET GLY GLU ASP LYS ILE LYS PHE LYS SEQRES 6 B 277 HIS ILE THR PRO LEU GLN GLU GLN SER LYS GLU VAL ALA SEQRES 7 B 277 ILE ARG ILE PHE GLN GLY CYS GLN PHE ARG SER VAL GLU SEQRES 8 B 277 ALA VAL GLN GLU ILE THR GLU TYR ALA LYS SER ILE PRO SEQRES 9 B 277 GLY PHE VAL ASN LEU ASP LEU ASN ASP GLN VAL THR LEU SEQRES 10 B 277 LEU LYS TYR GLY VAL HIS GLU ILE ILE TYR THR MET LEU SEQRES 11 B 277 ALA SER LEU MET ASN LYS ASP GLY VAL LEU ILE SER GLU SEQRES 12 B 277 GLY GLN GLY PHE MET THR ARG GLU PHE LEU LYS SER LEU SEQRES 13 B 277 ARG LYS PRO PHE GLY ASP PHE MET GLU PRO LYS PHE GLU SEQRES 14 B 277 PHE ALA VAL LYS PHE ASN ALA LEU GLU LEU ASP ASP SER SEQRES 15 B 277 ASP LEU ALA ILE PHE ILE ALA VAL ILE ILE LEU SER GLY SEQRES 16 B 277 ASP ARG PRO GLY LEU LEU ASN VAL LYS PRO ILE GLU ASP SEQRES 17 B 277 ILE GLN ASP ASN LEU LEU GLN ALA LEU GLU LEU GLN LEU SEQRES 18 B 277 LYS LEU ASN HIS PRO GLU SER SER GLN LEU PHE ALA LYS SEQRES 19 B 277 LEU LEU GLN LYS MET THR ASP LEU ARG GLN ILE VAL THR SEQRES 20 B 277 GLU HIS VAL GLN LEU LEU GLN VAL ILE LYS LYS THR GLU SEQRES 21 B 277 THR ASP MET SER LEU HIS PRO LEU LEU GLN GLU ILE TYR SEQRES 22 B 277 LYS ASP LEU TYR

HET C03 A 478 40 HET C03 B 478 40 HET TRS A 479 8

HETNAM C03 (2R)-2-(4-CHLORO-3-{[3-(6-METHOXY-1,2-BENZISOXAZOL-3- HETNAM 2 C03 YL)-2-METHYL-6-(TRIFLUOROMETHOXY)-1H-INDOL-1- HETNAM 3 C03 YL]METHYL}PHENOXY)PROPANOIC ACID HETNAM TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL

HETSYN TRS TRIS BUFFER

FORMUL 3 C03 2(C28 H22 CL F3 N2 O6) FORMUL 5 TRS C4 H12 N O3 1+ FORMUL 6 HOH *93(H2 O)

HELIX 1 1 ASN A 205 PHE A 226 1 22 HELIX 2 2 THR A 229 THR A 238 1 10 HELIX 3 3 ILE A 279 LYS A 301 1 23 HELIX 4 4 GLY A 305 LEU A 309 5 5 HELIX 5 5 ASP A 310 SER A 332 1 23 HELIX 6 6 ARG A 350 SER A 355 1 6 HELIX 7 7 ARG A 357 GLY A 361 5 5 HELIX 8 8 MET A 364 ASN A 375 1 12 HELIX 9 9 ALA A 376 GLU A 378 5 3 HELIX 10 10 ASP A 380 LEU A 393 1 14 HELIX 11 11 ASN A 402 HIS A 425 1 24 HELIX 12 12 GLN A 430 GLU A 460 1 31 HELIX 13 13 HIS A 466 ASP A 475 1 10 HELIX 14 14 ALA B 209 PHE B 226 1 18 HELIX 15 15 THR B 229 LEU B 237 1 9 HELIX 16 16 ALA B 278 SER B 302 1 25 HELIX 17 17 GLY B 305 LEU B 309 5 5 HELIX 18 18 ASP B 310 LEU B 333 1 24 HELIX 19 19 ARG B 350 SER B 355 1 6 HELIX 20 20 ARG B 357 ASP B 362 1 6 HELIX 21 21 MET B 364 LEU B 377 1 14 HELIX 22 22 ASP B 380 LEU B 393 1 14 HELIX 23 23 ASN B 402 HIS B 425 1 24 HELIX 24 24 GLN B 430 LEU B 453 1 24 HELIX 25 25 HIS B 466 TYR B 473 1 8

SHEET 1 A 4 PHE A 247 ILE A 249 0 SHEET 2 A 4 GLY A 346 THR A 349 1 O PHE A 347 N ILE A 249 SHEET 3 A 4 GLY A 338 ILE A 341 -1 N VAL A 339 O MET A 348 SHEET 4 A 4 MET A 334 ASN A 335 -1 N ASN A 335 O GLY A 338 SHEET 1 B 3 PHE B 247 ILE B 249 0 SHEET 2 B 3 GLY B 346 THR B 349 1 O PHE B 347 N ILE B 249 SHEET 3 B 3 GLY B 338 ILE B 341 -1 N ILE B 341 O GLY B 346

SITE 1 AC1 20 PHE A 226 GLY A 284 CYS A 285 ARG A 288 SITE 2 AC1 20 SER A 289 ALA A 292 ILE A 296 ILE A 326 SITE 3 AC1 20 TYR A 327 MET A 329 LEU A 330 VAL A 339 SITE 4 AC1 20 LEU A 340 ILE A 341 SER A 342 LEU A 353 SITE 5 AC1 20 PHE A 363 MET A 364 HIS A 449 TRS A 479 SITE 1 AC2 18 PHE B 226 CYS B 285 ARG B 288 SER B 289 SITE 2 AC2 18 ALA B 292 ILE B 296 ILE B 326 TYR B 327 SITE 3 AC2 18 MET B 329 LEU B 330 LEU B 333 VAL B 339 SITE 4 AC2 18 LEU B 340 ILE B 341 SER B 342 LEU B 353 SITE 5 AC2 18 MET B 364 HIS B 449 SITE 1 AC3 11 PHE A 282 GLN A 286 SER A 289 HIS A 323 SITE 2 AC3 11 PHE A 363 HIS A 449 LEU A 453 LEU A 465 SITE 3 AC3 11 LEU A 469 TYR A 473 C03 A 478

CRYST1 92.148 59.859 118.287 90.00 103.76 90.00 C 1 2 1 8

ORIGX1 1.000000 0.000000 0.000000 0.00000

ORIGX2 0.000000 1.000000 0.000000 0.00000

ORIGX3 0.000000 0.000000 1.000000 0.00000

SCALE1 0.010852 0.000000 0.002658 0.00000

SCALE2 0.000000 0.016706 0.000000 0.00000

SCALE3 0.000000 0.000000 0.008704 0.00000